Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapy.

Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapy. Abstract Text:

Restenosis is a major problem after balloon angioplasty and stent implantation. The aim of this study is to introduce gadolinium neutron capture brachytherapy (GdNCB) as a suitable modality for treatment of stenosis. The utility of GdNCB in intravascular brachytherapy (IVBT) of stent stenosis is investigated by using the GEANT4 and MCNP4B Monte Carlo radiation transport codes. To study capture rate, Kerma, absorbed dose and absorbed dose rate around a Gd-containing stent activated with neutrons, a 30 mm long, 5 mm diameter gadolinium foil is chosen. The input data is a neutron spectrum used for clinical neutron capture therapy in Studsvik, Sweden. Thermal neutron capture in gadolinium yields a spectrum of high-energy gamma photons, which due to the build-up effect gives an almost flat dose delivery pattern to the first 4 mm around the stent. The absorbed dose rate is 1.33 Gy/min, 0.25 mm from the stent surface while the dose to normal tissue is in order of 0.22 Gy/min, i.e., a factor of 6 lower. To spare normal tissue further fractionation of the dose is also possible. The capture rate is relatively high at both ends of the foil. The dose distribution from gamma and charge particle radiation at the edges and inside the stent contributes to a nonuniform dose distribution. This will lead to higher doses to the surrounding tissue and may prevent stent edge and in-stent restenosis. The position of the stent can be verified and corrected by the treatment plan prior to activation. Activation of the stent by an external neutron field can be performed days after catherization when the target cells start to proliferate and can be expected to be more radiation sensitive. Another advantage of the nonradioactive gadolinium stent is the possibility to avoid radiation hazard to personnel.

Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapy. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Medical physics

VOLUME: 33

Page Numbers: 46-51

Journal Abbreviation:

ISSN: 0094-2405

DAY: 26

MONTH: Jan

YEAR: 2006

Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 425746

Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapy. Keywords Mesh Terms:

KEYWORDS: Stents

MESH TERMS: methods

Chemical & Substance for Abstract: Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapy. Information

Substance Name: Gadolinium

Registry Number: 7440-54-2

Grant and Affiliation Information for Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapy.

AFFILIATION: Division of Biomedical Radiation Sciences, Department of Oncology, Radiology and Clinical Immunology, Rudbeck Laboratory, Uppsala University, SE-751 85 Uppsala, Sweden. shirin@enger.se

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Med Phys

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Gadolinium neutron capture brachytherapy GdNCB, a new treatment method for intravascular brachytherapy Related Publications

• Antipyrine clearance during experimental and occupational exposure to toluene.
• Argyrophil reaction in rectal carcinoids.
• Characterization of (111)In and (177)Lu-labeled antibodies binding to CD44v6 using a novel automated radioimmunoassay.
• Characterization of the immunoglobulin A heavy chain gene of the Atlantic bottlenose dolphin (Tursiops truncatus).
• Cross-fire doses from beta-emitting radionuclides in targeted radiotherapy. A theoretical study based on experimentally measured tumor characteristics.
• Distribution and stability in the rat of a 76Br/125I-labelled polypeptide, epidermal growth factor.
• Estimation of the parenchymal-cell content of the parathyroid gland, using density-gradient columns. Preliminary report.
• Facial expressions of emotion (KDEF): identification under different display-duration conditions.
• Gadolinium neutron capture brachytherapy (GdNCB), a new treatment method for intravascular brachytherapy.
• Immuno-PET of undifferentiated thyroid carcinoma with radioiodine-labelled antibody cMAb U36: application to antibody tumour uptake studies.
• Measurements of electric field strength in gas insulated high-voltage components using infrared diode laser absorption spectroscopy.
• Neuroendocrine tumours of the upper gastrointestinal tract and pancreas.
• On self-sterility and inbreeding effect in tetraploid rye.
• Oral sugar clearance; its influence on dental caries activity.
• Production of 76Br and its use in labeling proteins.
• Vitamin-D-induced hypercalcaemia and its effect on serum gastrin, gastrin cells and antral gastrin in parathyroidectomized rats.
• X-ray indicator as an aid in surgical correction of mandibular prognathism.
• [Mechanism of dental calculus formation]
• [Method of bridge repair.]